Choose language
Do you want to set the chosen language as default?
Yes, set as default

Price

US$ -

variation (12m)

0,00% Logo

p/l

-22,41

p/vp

5,61

DIVIDEND YIELD

0,00%
graph

price BGNE

BVMF
BGNE
If you had invested
If you had invested
years ago
6 months
1 year
5 years
10 years
ago, today you would have
ago, today you would have:
*The figure considers the reinvestment of dividends.

Profitability of BGNE

1 month
3 months
1 year
2 years
5 years
10 years
profitability
1 month
0,00%
3 months
0,00%
1 year
0,00%
2 years
0,00%
5 years
0,00%
10 years
0,00%

real profitability

profitability minus inflation.

1 month
0,00%
3 months
0,00%
1 year
0,00%
2 years
0,00%
5 years
0,00%
10 years
0,00%
Estatistica

Indicators BGNE

check out the fundamentals of BeiGene shares

P/E

-22,41
Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

5,81
Sector: -4,23 Industry: -4,23

P/BV

5,61
Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

0,00%
Sector: - Industry: -

ROA

-14,76%
Sector: -63,87% Industry: -63,87%

ROE

-25,04%
Sector: -70,87% Industry: -70,87%

ROIC

-19,43%
Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

-25,94%
Sector: -41,75% Industry: -41,75%

GROSS MARGIN

83,74%
Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

-26,31%
Sector: -41,04% Industry: -41,04%

P/EBITDA

-26,51
Sector: -3,65 Industry: -3,65

P/EBIT

-22,10
Sector: -3,64 Industry: -3,64

P/ASSET

3,31
Sector: 1,41 Industry: 1,41

BVPS

32,42
Sector: 1,84 Industry: 1,84

EPS

-8,12
Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,59
Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

60,76%
Sector: - Industry: -

CAGR PROFITS 5 YEARS

-11,63%
Sector: - Industry: -
statistics

BGNE indicators history

Buy And Hold Investor Checklist

Buy and hold investor checklist on BeiGene

This checklist tool is provided for informational purposes only and does not constitute an investment recommendation. The score is based on market parameters but does not guarantee future results. To understand how the scoring system works.

Stocks comparator

graph

comparison of BGNE with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.
Cotação

Dividend History BGNE

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY

Logo BeiGene

BeiGene Ltd.

Average user rating I10

4.0 (4 people)

Estados Unidos

Estados Unidos

15 years

Foundation: 2010

2016

Year of debut on the stock exchange - 9 years

5.300

Employees

Market value

US$ 19,28 Billions

US$ 19,28 Billions

Net worth

US$ 3,44 Billions

US$ 3.436.070.000,00

Assets

US$ 5,83 Billions

US$ 5.830.860.000,00

Total Number of Shares

106,00 Milhões

106.000.000

Average Daily Trading Volume

US$ 370,98 Thousand

US$ 370.981,82

Sector

Health Care

Industry

Biotechnology

Shares

BGNE
receitas e lucros

BGNE revenue and profits

graph

PROFIT X PRICE BGNE

resultados

BGNE results

DRAG THE FRAME TO SEE MORE DATA
Resultados

BGNE cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

evolution of assets - BGNE

Pontos Relevantes

BGNE balance sheet

DRAG THE FRAME TO SEE MORE DATA
Discover more assets
Logo Biofrontera

BFRA - Biofrontera

US$ - -0,00% (12M)
P/L

0,00

DY

0,00%

ROE

-893,55%

P/VP

0,00
Logo McKesson

MCK - McKesson

US$ 763,55 51,69% (12M)
P/L

24,89

DY

0,40%

ROE

-429,55%

P/VP

-106,90
Logo Cardinal Health

CAH - Cardinal Health

US$ 156,88 42,09% (12M)
P/L

26,56

DY

1,31%

ROE

-52,54%

P/VP

-13,96
Logo Johnson & Johnson

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12M)
P/L

17,80

DY

2,69%

ROE

32,50%

P/VP

5,78
Logo Merck & Co.

MRK - Merck & Co.

US$ 85,99 --18,73% (12M)
P/L

12,67

DY

3,59%

ROE

36,03%

P/VP

4,56
Logo AbbVie

ABBV - AbbVie

US$ 230,50 23,82% (12M)
P/L

108,79

DY

2,79%

ROE

-2.726,81%

P/VP

-2.966,40
Logo Pfizer

PFE - Pfizer

US$ 24,78 --8,77% (12M)
P/L

16,92

DY

6,25%

ROE

10,33%

P/VP

1,75
Logo AstraZeneca

AZN - AstraZeneca

US$ 84,53 11,61% (12M)
P/L

28,39

DY

1,83%

ROE

20,79%

P/VP

5,90
Logo Biofrontera

BFRA - Biofrontera

US$ - -0,00% (12 M)
P/L

0,00

DY

0,00%

ROE

-893,55%

P/VP

0,00
Logo McKesson

MCK - McKesson

US$ 763,55 51,69% (12 M)
P/L

24,89

DY

0,40%

ROE

-429,55%

P/VP

-106,90
Logo Cardinal Health

CAH - Cardinal Health

US$ 156,88 42,09% (12 M)
P/L

26,56

DY

1,31%

ROE

-52,54%

P/VP

-13,96
Logo Johnson & Johnson

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12 M)
P/L

17,80

DY

2,69%

ROE

32,50%

P/VP

5,78
Logo Merck & Co.

MRK - Merck & Co.

US$ 85,99 --18,73% (12 M)
P/L

12,67

DY

3,59%

ROE

36,03%

P/VP

4,56
Logo AbbVie

ABBV - AbbVie

US$ 230,50 23,82% (12 M)
P/L

108,79

DY

2,79%

ROE

-2.726,81%

P/VP

-2.966,40
Logo Pfizer

PFE - Pfizer

US$ 24,78 --8,77% (12 M)
P/L

16,92

DY

6,25%

ROE

10,33%

P/VP

1,75
Logo AstraZeneca

AZN - AstraZeneca

US$ 84,53 11,61% (12 M)
P/L

28,39

DY

1,83%

ROE

20,79%

P/VP

5,90

Frequently Asked Questions

What is the price of BeiGene (BGNE) today?

The price of BeiGene (BGNE) today is US$ 0,00, with a variation of 0% compared to the last year. The price of BeiGene (BGNE) started the year trading around US$ 184,71 and today it is at US$ 0,00. Follow the real-time price chart, the historical price of BeiGene (BGNE), and stock data from Ibovespa and international markets.

When does BeiGene (BGNE) pay dividends?

BeiGene (BGNE) did not distribute dividends in the last year.

BeiGene (BGNE) is it worth it?

Currently, BeiGene (BGNE) is priced at US$ 0,00, with a P/E of -22,41%, representing a deviation of -52,53% from its historical average P/E. In the last year, the stock showed a variation of 0% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 0,00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of BeiGene (BGNE)?

Investing in stocks of BeiGene (BGNE) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of BeiGene (BGNE) yield today?

The yield of BeiGene (BGNE) was 0,00% in the last month, 0,00% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of BeiGene (BGNE) today, the total investment would be US$ 0,00, based on the current price of US$ 0,00.

If past performance were to repeat, the return on your investment would be:

  • In 1 year: US$ 0,00
  • In 5 years: US$ 0,00
  • In 10 years: 0,00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.